$7.53 Billion is the total value of Paulson & Co.'s 100 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 185.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TWX | Buy | TIME WARNER INC | $295,475,000 | +7.2% | 3,024,000 | +5.9% | 3.92% | +12.9% |
TMUS | New | T MOBILE US INC | $267,409,000 | – | 4,140,100 | +100.0% | 3.55% | – |
DISH | New | DISH NETWORK CORPcl a | $219,047,000 | – | 3,450,100 | +100.0% | 2.91% | – |
NXPI | Buy | NXP SEMICONDUCTORS N V | $117,193,000 | +220.6% | 1,132,300 | +203.6% | 1.56% | +237.3% |
MJN | Buy | MEAD JOHNSON NUTRITION CO | $105,489,000 | +4741.2% | 1,184,200 | +3744.8% | 1.40% | +5085.2% |
BKD | New | BROOKDALE SR LIVING INC | $67,707,000 | – | 5,041,500 | +100.0% | 0.90% | – |
ALXN | Buy | ALEXION PHARMACEUTICALS INC | $40,518,000 | +116.0% | 334,200 | +117.9% | 0.54% | +128.0% |
STE | Buy | STERIS PLC | $29,416,000 | +39.2% | 423,500 | +35.1% | 0.39% | +46.6% |
FB | Buy | FACEBOOK INCcl a | $26,322,000 | +26.4% | 185,300 | +2.4% | 0.35% | +33.2% |
L100PS | New | ARCONIC INC | $25,900,000 | – | 983,300 | +100.0% | 0.34% | – |
PANW | New | PALO ALTO NETWORKS INC | $17,556,000 | – | 155,800 | +100.0% | 0.23% | – |
GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $17,501,000 | +53.5% | 415,100 | +40.2% | 0.23% | +61.1% |
PFE | Buy | PFIZER INC | $13,941,000 | +21.9% | 407,500 | +15.7% | 0.18% | +28.5% |
SNAP | New | SNAP INCput | $13,067,000 | – | 580,000 | +100.0% | 0.17% | – |
SD | Buy | SANDRIDGE ENERGY INC | $12,324,000 | +113.6% | 666,535 | +172.0% | 0.16% | +124.7% |
FGL | New | FIDELITY & GTY LIFE | $11,120,000 | – | 400,000 | +100.0% | 0.15% | – |
XENT | New | INTERSECT ENT INC | $10,978,000 | – | 640,100 | +100.0% | 0.15% | – |
FDX | Buy | FEDEX CORP | $9,660,000 | +371.7% | 49,500 | +350.0% | 0.13% | +392.3% |
ESPR | Buy | ESPERION THERAPEUTICS INC NE | $8,185,000 | +541.0% | 231,800 | +127.3% | 0.11% | +581.2% |
RAI | Buy | REYNOLDS AMERICAN INC | $7,941,000 | +33.7% | 126,000 | +18.9% | 0.10% | +40.0% |
WBMD | New | WEBMD HEALTH CORP | $7,665,000 | – | 145,500 | +100.0% | 0.10% | – |
Z | New | ZILLOW GROUP INCcl c cap stk | $5,606,000 | – | 166,500 | +100.0% | 0.07% | – |
AMZN | New | AMAZON COM INC | $4,876,000 | – | 5,500 | +100.0% | 0.06% | – |
SERV | New | SERVICEMASTER GLOBAL HLDGS I | $4,760,000 | – | 114,000 | +100.0% | 0.06% | – |
TEAM | New | ATLASSIAN CORP PLCcl a | $4,715,000 | – | 157,415 | +100.0% | 0.06% | – |
MBBYF | New | MOBILEYE N V AMSTELVEEN | $4,666,000 | – | 76,000 | +100.0% | 0.06% | – |
MON | New | MONSANTO CO NEW | $4,019,000 | – | 35,500 | +100.0% | 0.05% | – |
DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $2,755,000 | +301.0% | 463,000 | +166.1% | 0.04% | +311.1% |
SRPT | New | SAREPTA THERAPEUTICS INC | $2,312,000 | – | 78,101 | +100.0% | 0.03% | – |
HW | New | HEADWATERS INC | $2,348,000 | – | 100,000 | +100.0% | 0.03% | – |
KTWO | New | K2M GROUP HLDGS INC | $1,979,000 | – | 96,500 | +100.0% | 0.03% | – |
RIGL | Buy | RIGEL PHARMACEUTICALS INC | $1,821,000 | +97.3% | 550,000 | +41.9% | 0.02% | +100.0% |
TRVN | New | TREVENA INC | $1,496,000 | – | 407,626 | +100.0% | 0.02% | – |
CNCE | New | CONCERT PHARMACEUTICALS INC | $1,198,000 | – | 70,229 | +100.0% | 0.02% | – |
CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $1,099,000 | – | 50,500 | +100.0% | 0.02% | – |
NTLA | New | INTELLIA THERAPEUTICS INC | $1,107,000 | – | 78,600 | +100.0% | 0.02% | – |
EDIT | New | EDITAS MEDICINE INC | $1,116,000 | – | 50,000 | +100.0% | 0.02% | – |
TNDM | New | TANDEM DIABETES CARE INC | $600,000 | – | 500,000 | +100.0% | 0.01% | – |
MULE | New | MULESOFT INCcl a added | $487,000 | – | 20,000 | +100.0% | 0.01% | – |
ARCC | New | ARES CAP CORP | $0 | – | 1 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
About Paulson & Co.
Paulson & Co. is a New York-based investment management firm founded by John Paulson in 1994. The firm is known for its expertise in event-driven investing, which involves taking advantage of market inefficiencies created by corporate events such as mergers, acquisitions, bankruptcies, and spin-offs. Paulson & Co. manages approximately $9 billion in assets and has a team of over 100 professionals.
John Paulson, the founder and CEO of Paulson & Co., is a renowned hedge fund manager who made a fortune by betting against the subprime mortgage market in 2007. He is considered one of the most successful investors of his generation, with a net worth of over $4 billion. Paulson is actively involved in the management of the firm and oversees the investment strategy.
Paulson & Co. has a strong track record of generating high returns for its investors. The firm's flagship fund, the Paulson Advantage Fund, has delivered an average annual return of 12.5% since its inception in 1994. The fund has also outperformed the S&P 500 index in 16 out of the past 22 years.
In recent years, Paulson & Co. has faced some challenges, including a decline in assets under management and a series of high-profile losses. However, the firm has remained committed to its investment philosophy and has continued to generate strong returns for its investors. With a talented team of professionals and a proven track record of success, Paulson & Co. is well-positioned to continue delivering value to its clients in the years ahead.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NOVAGOLD RESOURCES INC | 42 | Q3 2023 | 12.0% |
INTERNATIONAL TOWER HILL MINE | 42 | Q3 2023 | 3.4% |
IAMGOLD CORP | 42 | Q3 2023 | 0.5% |
ANGLOGOLD ASHANTI-SPON ADR | 41 | Q2 2023 | 7.9% |
AGNICO EAGLE MINES LTD | 34 | Q3 2023 | 3.8% |
SPDR GOLD TRUST | 33 | Q1 2022 | 13.3% |
TRILOGY METALS INC NEW | 29 | Q3 2023 | 0.9% |
ENDO INTL PLC | 28 | Q2 2022 | 3.4% |
CAESARS ENTMT CORP | 27 | Q4 2019 | 4.6% |
TIM PARTICIPACOES SA-ADR | 26 | Q3 2020 | 2.4% |
View Paulson & Co.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Thryv Holdings, Inc. | February 14, 2023 | 2,000,000 | 5.8% |
Endo International plc | February 14, 2022 | 17,327,012 | 7.4% |
BrightSphere Investment Group Inc. | December 22, 2021 | 8,950,121 | 19.8% |
PERPETUA RESOURCES CORP. | August 27, 2021 | 20,929,280 | 33.3% |
Bausch Health Companies Inc. | May 15, 2020 | 25,839,035 | 7.3% |
OVERSEAS SHIPHOLDING GROUP INC | April 13, 2020 | 6,300,000 | 7.3% |
SYNTHESIS ENERGY SYSTEMS INC | February 14, 2020 | 165,648 | 10.5% |
Callon Petroleum Co | November 18, 2019 | 10,338,663 | 4.5% |
International Seaways, Inc. | July 03, 2019 | 1,459,119 | 5.0% |
AKORN INCSold out | February 14, 2018 | 0 | 0.0% |
View Paulson & Co.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
4 | 2024-01-22 |
SC 13D/A | 2024-01-22 |
13F-HR | 2023-11-14 |
SC 13G | 2023-11-13 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
View Paulson & Co.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.